Araştırma Makalesi

Effects of bacterial vaginosis and its treatment on sexual functions: A cross-sectional questionnaire study

Cilt: 4 Sayı: 2 1 Ağustos 2019
PDF İndir
EN TR

Effects of bacterial vaginosis and its treatment on sexual functions: A cross-sectional questionnaire study

Abstract

Aim: To investigate the effects of bacterial vaginosis, which is the most frequent vaginal infection in women, and its treatment on sexual functions.

Methods: Patients who had applied to our gynecology outpatient clinic with bacterial vaginosis based on the culture results were included in this observational questionnaire study. Patients with an accompanying disease possibly resulting in sexual dysfunction and those with vaginitis etiology other than bacterial vaginosis were excluded from the study. Patients were asked to fill the Female Sexual Function Index (FSFI) during the diagnosis of bacterial vaginosis and 1 month later than the treatment.

Results: Seventy-two patients who had applied to our outpatient clinic between January 2018 and January 2019 and who met the study criteria were included in this study. Statistically significant improvement was found in post-treatment orgasm and pain scores and in total FSFI scores of the patients upon comparison of FSFI scores of patients before and after the treatment (p<0.001). However, no statistically significant differences were found in sexual desire, arousal, lubricity and general satisfaction scores before and after the treatment (p>0.05 for all).

Conclusion: It was found that sexual dysfunction was more common in patients with bacterial vaginosis and improvement was seen in some sexual functions with treatment.

Keywords

Kaynakça

  1. 1. Verstraelen H, Swidsinski A. The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment. Current Opinion Infectious Diseases. 2013;26:86-9.
  2. 2. Li M, Li L, Wang R, Yan SM, Ma XY, Jiang S, et al. Prevalence and risk factors for bacterial vaginosis and cervicitis among 511 female workers attending gynecological examination in Changchun, China. Taiwan J Obstet Gynecol. 2019;58:385-9.
  3. 3. AlAwlaqi A, Amor H, Hammadeh ME. Role of hormones in hypoactive sexual desire disorder and current treatment. J Turk Ger Gynecol Assoc. 2017;18:210-8.
  4. 4. Salonia A, Munarriz RM, Naspro R, Nappi RE, Briganti A, Chionna R et al. Women's sexual dysfunction: a pathophysiological review. BJU Int. 2004;93:1156-64.
  5. 5. Clayton AH, Valladares Juarez EM. Female Sexual Dysfunction. Med Clin North Am. 2019;103:681-98.
  6. 6. Pauls RN, Kleeman SD, Karram MM. Female sexual dysfunction: principles of diagnosis and therapy. ObstetGynecolSurv. 2005;60:196-205.
  7. 7. Krleža-Jerić K, Lemmens T. 7th Revision of the Declaration of Helsinki: Good News for the Transparency of Clinical Trials. Croat Med J. 2009;50:105-10.
  8. 8. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191-208.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Klinik Tıp Bilimleri

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

1 Ağustos 2019

Gönderilme Tarihi

1 Temmuz 2019

Kabul Tarihi

22 Temmuz 2019

Yayımlandığı Sayı

Yıl 2019 Cilt: 4 Sayı: 2

Kaynak Göster

Vancouver
1.Coşkun Şimşir, Bora Coşkun, Buğra Coşkun, Aynur Adeviye Erşahin, Tolga Ecemiş. Effects of bacterial vaginosis and its treatment on sexual functions: A cross-sectional questionnaire study. Arch Clin Exp Med. 01 Ağustos 2019;4(2):99-102. doi:10.25000/acem.585436

Cited By